RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shanrong Biotechnology Stock

Shanrong Biotechnology EBIT 2024

Shanrong Biotechnology EBIT

-4.81 M USD

Ticker

SRBT

ISIN

US81946R1077

In 2024, Shanrong Biotechnology's EBIT was -4.81 M USD, a 99.1% increase from the -2.42 M USD EBIT recorded in the previous year.

The Shanrong Biotechnology EBIT history

YEAREBIT (undefined USD)
2009-
2008-
2007-
2006-

Shanrong Biotechnology Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Shanrong Biotechnology, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Shanrong Biotechnology from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Shanrong Biotechnology’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Shanrong Biotechnology. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Shanrong Biotechnology’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Shanrong Biotechnology’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Shanrong Biotechnology’s growth potential.

Shanrong Biotechnology Revenue, EBIT and net profit per share

DateShanrong Biotechnology RevenueShanrong Biotechnology EBITShanrong Biotechnology Net Income
20091.32 M undefined-4.81 M undefined-5.08 M undefined
2008692,000 undefined-2.42 M undefined-2.72 M undefined
20070 undefined-33,000 undefined-40,000 undefined
20060 undefined-53,000 undefined-53,000 undefined

Shanrong Biotechnology stock margins

The Shanrong Biotechnology margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shanrong Biotechnology. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shanrong Biotechnology.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Shanrong Biotechnology's sales revenue. A higher gross margin percentage indicates that the Shanrong Biotechnology retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Shanrong Biotechnology's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Shanrong Biotechnology's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Shanrong Biotechnology's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Shanrong Biotechnology. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Shanrong Biotechnology's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Shanrong Biotechnology Margin History

Shanrong Biotechnology Gross marginShanrong Biotechnology Profit marginShanrong Biotechnology EBIT marginShanrong Biotechnology Profit margin
20090 %-362.96 %-383.32 %
20080 %-348.99 %-393.21 %
20070 %0 %0 %
20060 %0 %0 %

Shanrong Biotechnology Aktienanalyse

What does Shanrong Biotechnology do?

Shanrong Biotechnology Corp is an innovative and fast-growing company that specializes in the development and manufacture of biotechnology products. The company is based in Taiwan and was founded in 2014. Since then, it has become one of the leading companies in the industry. The history of Shanrong Biotechnology Corp dates back to a group of experts specializing in the development of biotechnological products. They recognized the importance of biotechnology in today's world and wanted to use their expertise to bring innovative products to the market. The company has experienced rapid expansion since its inception and now has branches in various countries. The business model of Shanrong Biotechnology Corp is based on the development and manufacture of biotechnology products that have a wide range of applications. The company focuses on research and development to drive innovation and introduce new products to the market. It works closely with its customers and continuously optimizes its products to ensure higher quality and customer satisfaction. Shanrong Biotechnology Corp is divided into different business divisions to organize its work more effectively. These divisions include: 1. Self-care products: The company offers a wide range of self-care products, including face masks, lotions, and creams. These products are tailored to the needs of consumers and have been developed using state-of-the-art technologies. 2. Diagnostics and genomic research: In diagnostics and genomic research, Shanrong Biotechnology Corp offers products for the identification of biomolecular markers that can be used in disease diagnosis and personalized therapies. 3. Animal health: In animal health, Shanrong Biotechnology Corp offers products for the prevention and treatment of diseases in livestock and pets. The products are tailored to the specific needs of the animals and help improve their health and well-being. 4. Agricultural biotechnology: Shanrong Biotechnology Corp offers a wide range of biotechnology products for improving plant growth and productivity, as well as combating plant diseases and pests. Shanrong Biotechnology Corp offers a wide range of products that are divided into various categories: 1. Face masks: The company offers a wide range of face masks tailored to the needs of different skin types. The face masks are available in various formulas to address specific skin issues such as acne, wrinkles, or lack of moisture. 2. Enzymes and enzyme cleaners: Shanrong Biotechnology Corp offers a wide range of biotechnological enzyme cleaners tailored to the needs of different applications. These products can be used in various industries such as textiles, food, cosmetics, and household cleaning. 3. Liposomes: Shanrong Biotechnology Corp offers a wide range of liposomes that can be used in the treatment of various diseases. Liposomes are small spherical vesicles that can be used for drug delivery and offer higher bioavailability. In conclusion, Shanrong Biotechnology Corp is an innovative company that specializes in the development and manufacture of biotechnology products. The company has experienced rapid expansion and now offers a wide range of products that can be used in various industries. It focuses on research and development to drive innovation and introduce new products to the market, working closely with its customers to ensure higher quality and customer satisfaction. Shanrong Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Shanrong Biotechnology's EBIT

Shanrong Biotechnology's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Shanrong Biotechnology's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Shanrong Biotechnology's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Shanrong Biotechnology’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Shanrong Biotechnology stock

How much did Shanrong Biotechnology achieve in EBIT for the current year?

In the current year, Shanrong Biotechnology has achieved an EBIT of -4.81 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Shanrong Biotechnology.

How has the EBIT of Shanrong Biotechnology developed in recent years?

The EBIT of Shanrong Biotechnology has increased by 99.101% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Shanrong Biotechnology?

The EBIT of Shanrong Biotechnology is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Shanrong Biotechnology pay?

Over the past 12 months, Shanrong Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Shanrong Biotechnology is expected to pay a dividend of 0 USD.

What is the dividend yield of Shanrong Biotechnology?

The current dividend yield of Shanrong Biotechnology is .

When does Shanrong Biotechnology pay dividends?

Shanrong Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Shanrong Biotechnology?

Shanrong Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Shanrong Biotechnology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Shanrong Biotechnology located?

Shanrong Biotechnology is assigned to the 'Industry' sector.

Wann musste ich die Aktien von Shanrong Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shanrong Biotechnology from 9/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/24/2024.

When did Shanrong Biotechnology pay the last dividend?

The last dividend was paid out on 9/24/2024.

What was the dividend of Shanrong Biotechnology in the year 2023?

In the year 2023, Shanrong Biotechnology distributed 0 USD as dividends.

In which currency does Shanrong Biotechnology pay out the dividend?

The dividends of Shanrong Biotechnology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shanrong Biotechnology

Our stock analysis for Shanrong Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanrong Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.